LGC and CCCMHPIE sign partnership agreement
LGC and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) today announced that they have signed a partnership agreement at the CPHI Conference in Shanghai.
Under the agreement, LGC will bring its international expertise in the pharmaceutical market and in high product quality to CCCMHPIE member companies and will offer services including:
- Market assessment and product registration
- Reference standards and product testing
- Training and consultancy in quality and laboratory design and operation
Dr Derek Craston, LGC director for Science and Technology, said: “We are proud to be collaborating with the CCCMHPIE, bringing our own international expertise in product quality and registration across the pharmaceuticals and healthcare markets. This announcement is a key element to our international growth strategy and we look forward to sharing our experience in this new developing market.”
Mr. Ni Rulin, president of CCCMHPIE said, “LGC is the global leading research institution focusing on lab services, drug testing and provision of reference standards with a long history of more than 100 years and LGC’s specialised background has been widely acknowledged. We believe that the collaboration between us will provide a special platform for Chinese companies to access the international market.”
CCCMHPIE is the leading and most influential national trade association in China with a mission to promote the international trade and cooperation in medicinal and health products. CCCMHPIE，directly under the Ministry of Commerce of China, has a diverse membership of more than 2,400 companies including most of the major manufacturers and trading companies of pharmaceutical and health products across China. The fields that CCCMHPIE covers range from Traditional Chinese Medicines (TCM), pharmaceuticals, preparations, medical devices and equipment, dressings, biopharmaceuticals, nutraceuticals, functional cosmetics to health products.